ProfileGDS5678 / 1450750_a_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 68% 68% 68% 67% 68% 68% 68% 67% 67% 68% 68% 68% 68% 67% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 14.1538968
GSM967853U87-EV human glioblastoma xenograft - Control 24.1805368
GSM967854U87-EV human glioblastoma xenograft - Control 34.1437168
GSM967855U87-EV human glioblastoma xenograft - Control 44.0681667
GSM967856U87-EV human glioblastoma xenograft - Control 54.1248368
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 14.1641568
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 24.2219668
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 34.0912167
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 44.0839167
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 14.1345468
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 24.1291368
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 34.1295868
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 44.129968
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 54.031667